These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 18482742

  • 1. Heterogeneity in the A33 protein impacts the cross-protective efficacy of a candidate smallpox DNA vaccine.
    Golden JW, Hooper JW.
    Virology; 2008 Jul 20; 377(1):19-29. PubMed ID: 18482742
    [Abstract] [Full Text] [Related]

  • 2. Polyclonal antibody cocktails generated using DNA vaccine technology protect in murine models of orthopoxvirus disease.
    Golden JW, Zaitseva M, Kapnick S, Fisher RW, Mikolajczyk MG, Ballantyne J, Golding H, Hooper JW.
    Virol J; 2011 Sep 20; 8():441. PubMed ID: 21933385
    [Abstract] [Full Text] [Related]

  • 3. Evaluating the orthopoxvirus type I interferon-binding molecule as a vaccine target in the vaccinia virus intranasal murine challenge model.
    Golden JW, Hooper JW.
    Clin Vaccine Immunol; 2010 Nov 20; 17(11):1656-65. PubMed ID: 20844086
    [Abstract] [Full Text] [Related]

  • 4. Targeting the vaccinia virus L1 protein to the cell surface enhances production of neutralizing antibodies.
    Golden JW, Josleyn MD, Hooper JW.
    Vaccine; 2008 Jun 25; 26(27-28):3507-15. PubMed ID: 18485547
    [Abstract] [Full Text] [Related]

  • 5. Characterization of chimpanzee/human monoclonal antibodies to vaccinia virus A33 glycoprotein and its variola virus homolog in vitro and in a vaccinia virus mouse protection model.
    Chen Z, Earl P, Americo J, Damon I, Smith SK, Yu F, Sebrell A, Emerson S, Cohen G, Eisenberg RJ, Gorshkova I, Schuck P, Satterfield W, Moss B, Purcell R.
    J Virol; 2007 Sep 25; 81(17):8989-95. PubMed ID: 17581986
    [Abstract] [Full Text] [Related]

  • 6. Epitope mapping by random peptide phage display reveals essential residues for vaccinia extracellular enveloped virion spread.
    He Y, Wang Y, Struble EB, Zhang P, Chowdhury S, Reed JL, Kennedy M, Scott DE, Fisher RW.
    Virol J; 2012 Sep 24; 9():217. PubMed ID: 23006741
    [Abstract] [Full Text] [Related]

  • 7. Active vaccination with vaccinia virus A33 protects mice against lethal vaccinia and ectromelia viruses but not against cowpoxvirus; elucidation of the specific adaptive immune response.
    Paran N, Lustig S, Zvi A, Erez N, Israely T, Melamed S, Politi B, Ben-Nathan D, Schneider P, Lachmi B, Israeli O, Stein D, Levin R, Olshevsky U.
    Virol J; 2013 Jul 10; 10():229. PubMed ID: 23842430
    [Abstract] [Full Text] [Related]

  • 8. Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates.
    Hooper JW, Custer DM, Thompson E.
    Virology; 2003 Feb 01; 306(1):181-95. PubMed ID: 12620810
    [Abstract] [Full Text] [Related]

  • 9. Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigens.
    Sakhatskyy P, Wang S, Zhang C, Chou TH, Kishko M, Lu S.
    Virology; 2008 Feb 05; 371(1):98-107. PubMed ID: 17950773
    [Abstract] [Full Text] [Related]

  • 10. A Nucleic Acid-Based Orthopoxvirus Vaccine Targeting the Vaccinia Virus L1, A27, B5, and A33 Proteins Protects Rabbits against Lethal Rabbitpox Virus Aerosol Challenge.
    Mucker EM, Golden JW, Hammerbeck CD, Kishimori JM, Royals M, Joselyn MD, Ballantyne J, Nalca A, Hooper JW.
    J Virol; 2022 Feb 09; 96(3):e0150421. PubMed ID: 34851148
    [Abstract] [Full Text] [Related]

  • 11. Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox.
    Hooper JW, Thompson E, Wilhelmsen C, Zimmerman M, Ichou MA, Steffen SE, Schmaljohn CS, Schmaljohn AL, Jahrling PB.
    J Virol; 2004 May 09; 78(9):4433-43. PubMed ID: 15078924
    [Abstract] [Full Text] [Related]

  • 12. Short-term and longer-term protective immune responses generated by subunit vaccination with smallpox A33, B5, L1 or A27 proteins adjuvanted with aluminum hydroxide and CpG in mice challenged with vaccinia virus.
    Xiao Y, Zeng Y, Schante C, Joshi SB, Buchman GW, Volkin DB, Middaugh CR, Isaacs SN.
    Vaccine; 2020 Aug 27; 38(38):6007-6018. PubMed ID: 32741672
    [Abstract] [Full Text] [Related]

  • 13. [Comparison of protective properties of the smallpox DNA-vaccine based on the variola virus A30L gene and its variant with modified codon usage].
    Maksiutov RA, Shchelkunov SN.
    Mol Gen Mikrobiol Virusol; 2011 Aug 27; (2):30-4. PubMed ID: 21786633
    [Abstract] [Full Text] [Related]

  • 14. An attenuated LC16m8 smallpox vaccine: analysis of full-genome sequence and induction of immune protection.
    Morikawa S, Sakiyama T, Hasegawa H, Saijo M, Maeda A, Kurane I, Maeno G, Kimura J, Hirama C, Yoshida T, Asahi-Ozaki Y, Sata T, Kurata T, Kojima A.
    J Virol; 2005 Sep 27; 79(18):11873-91. PubMed ID: 16140764
    [Abstract] [Full Text] [Related]

  • 15. Differential antigen requirements for protection against systemic and intranasal vaccinia virus challenges in mice.
    Kaufman DR, Goudsmit J, Holterman L, Ewald BA, Denholtz M, Devoy C, Giri A, Grandpre LE, Heraud JM, Franchini G, Seaman MS, Havenga MJ, Barouch DH.
    J Virol; 2008 Jul 27; 82(14):6829-37. PubMed ID: 18448519
    [Abstract] [Full Text] [Related]

  • 16. Serological responses to smallpox A33 antigen and monkeypox A35 antigen in healthy people and people living with HIV-1 from Guangzhou, China.
    Dai J, Li F, Yang Y, Tang X, Li L, Yu H.
    J Med Virol; 2023 May 27; 95(5):e28763. PubMed ID: 37212313
    [Abstract] [Full Text] [Related]

  • 17. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.
    Berhanu A, Wilson RL, Kirkwood-Watts DL, King DS, Warren TK, Lund SA, Brown LL, Krupkin AK, Vandermay E, Weimers W, Honeychurch KM, Grosenbach DW, Jones KF, Hruby DE.
    J Virol; 2008 Apr 27; 82(7):3517-29. PubMed ID: 18199639
    [Abstract] [Full Text] [Related]

  • 18. An epitope conserved in orthopoxvirus A13 envelope protein is the target of neutralizing and protective antibodies.
    Xu C, Meng X, Yan B, Crotty S, Deng J, Xiang Y.
    Virology; 2011 Sep 15; 418(1):67-73. PubMed ID: 21810533
    [Abstract] [Full Text] [Related]

  • 19. Immunization with a single extracellular enveloped virus protein produced in bacteria provides partial protection from a lethal orthopoxvirus infection in a natural host.
    Fang M, Cheng H, Dai Z, Bu Z, Sigal LJ.
    Virology; 2006 Feb 05; 345(1):231-43. PubMed ID: 16256161
    [Abstract] [Full Text] [Related]

  • 20. Side-by-side comparison of gene-based smallpox vaccine with MVA in nonhuman primates.
    Golden JW, Josleyn M, Mucker EM, Hung CF, Loudon PT, Wu TC, Hooper JW.
    PLoS One; 2012 Feb 05; 7(7):e42353. PubMed ID: 22860117
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.